Nrx pharmaceuticals' interim ceo and other leaders to present at 21st annual needham virtual healthcare conference

Company to present corporate update during investor webcast, april 14, 2022, at 4:30pm et radnor, pa. , april 8, 2022 /prnewswire/ -- nrx pharmaceuticals, inc. (nasdaq: nrxp) ("nrx pharmaceuticals"), a clinical-stage, biopharmaceutical company, today announced its interim chief executive officer, robert besthof, and other executive leaders will be presenting updates to the company's business at the 21st annual needham virtual healthcare conference.
NRXP Ratings Summary
NRXP Quant Ranking